Literature DB >> 23901887

Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

Saijie Zhu1, Mengmeng Niu, Hannah O'Mary, Zhengrong Cui.   

Abstract

It is increasingly evident that tumor-associated macrophages (TAMs) play an important role in tumor invasion, proliferation, and metastasis. While delivery of drugs, imaging agents, and vaccines to TAMs was achieved by exploiting membrane receptors on TAMs, the uptake by normal macrophages remains an issue. In this communication, we report a PEG-sheddable, mannose-modified nanoparticle platform that can efficiently target TAMs via mannose-mannose receptor recognition after acid-sensitive PEG shedding in the acidic tumor microenvironment, while their uptake by normal macrophages in the mononuclear phagocyte system (MPS) organs was significantly reduced due to effective PEG shielding at neutral pH. These nanoparticles have the potential to target drugs of interest to TAMs, with decreased uptake by normal macrophages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23901887      PMCID: PMC3946577          DOI: 10.1021/mp400216r

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  51 in total

1.  Macrophages in innate and acquired immunity.

Authors:  Homer L Twigg
Journal:  Semin Respir Crit Care Med       Date:  2004-02       Impact factor: 3.119

Review 2.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

3.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo.

Authors:  Greg F Walker; Carolin Fella; Jaroslav Pelisek; Julia Fahrmeir; Sabine Boeckle; Manfred Ogris; Ernst Wagner
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

4.  Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity.

Authors:  Saijie Zhu; Dharmika S P Lansakara-P; Xinran Li; Zhengrong Cui
Journal:  Bioconjug Chem       Date:  2012-04-18       Impact factor: 4.774

Review 5.  Differentiation and gene expression profile of tumor-associated macrophages.

Authors:  Astrid Schmieder; Julia Michel; Kathrin Schönhaar; Sergij Goerdt; Kai Schledzewski
Journal:  Semin Cancer Biol       Date:  2012-02-13       Impact factor: 15.707

6.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.

Authors:  Qianjun He; Jiamin Zhang; Jianlin Shi; Ziyan Zhu; Linxia Zhang; Wenbo Bu; Limin Guo; Yu Chen
Journal:  Biomaterials       Date:  2009-10-31       Impact factor: 12.479

7.  Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.

Authors:  Dongin Kim; Eun Seong Lee; Kyung Taek Oh; Zhong Gao Gao; You Han Bae
Journal:  Small       Date:  2008-11       Impact factor: 13.281

8.  The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.

Authors:  Saijie Zhu; Piyanuch Wonganan; Dharmika S P Lansakara-P; Hannah L O'Mary; Yue Li; Zhengrong Cui
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479

9.  Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.

Authors:  Deepak Singodia; Ashwni Verma; Rahul K Verma; Prabhat Ranjan Mishra
Journal:  Nanomedicine       Date:  2011-07-23       Impact factor: 5.307

10.  Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages.

Authors:  Ryusaku Nagayoshi; Taku Nagai; Kakushi Matsushita; Katsuaki Sato; Nobuhiko Sunahara; Takemasa Matsuda; Tadashi Nakamura; Setsuro Komiya; Masanori Onda; Takami Matsuyama
Journal:  Arthritis Rheum       Date:  2005-09
View more
  68 in total

Review 1.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

Review 2.  Progress on Modulating Tumor-Associated Macrophages with Biomaterials.

Authors:  Meilyn Sylvestre; Courtney A Crane; Suzie H Pun
Journal:  Adv Mater       Date:  2019-09-27       Impact factor: 30.849

Review 3.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

4.  Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.

Authors:  Fan Zhang; Panagiotis Mastorakos; Manoj K Mishra; Antonella Mangraviti; Lee Hwang; Jinyuan Zhou; Justin Hanes; Henry Brem; Alessandro Olivi; Betty Tyler; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

Review 5.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Authors:  Chayanon Ngambenjawong; Heather H Gustafson; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

6.  Nanoparticle Design Strategies for Effective Cancer Immunotherapy.

Authors:  Praveena Velpurisiva; Aniket Gad; Brandon Piel; Rahul Jadia; Prakash Rai
Journal:  J Biomed (Syd)       Date:  2017

Review 7.  Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Authors:  Olga V Zhukova; Tatiana F Kovaleva; Evgenia V Arkhipova; Sergey A Ryabov; Irina V Mukhina
Journal:  Biomed Rep       Date:  2020-08-28

8.  Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.

Authors:  Hongliang He; Quan Yuan; Jinghua Bie; Ryan L Wallace; Paul J Yannie; Jing Wang; Michael G Lancina; Olga Yu Zolotarskaya; William Korzun; Hu Yang; Shobha Ghosh
Journal:  Transl Res       Date:  2017-11-21       Impact factor: 7.012

Review 9.  Exploring the tumor microenvironment with nanoparticles.

Authors:  Lei Miao; Leaf Huang
Journal:  Cancer Treat Res       Date:  2015

Review 10.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.